Joel Sugar
About
In The Last Decade
Joel Sugar
16 papers receiving 477 citations
Peers
Comparison fields: 5 of 51
- Radiology, Nuclear Medicine and Imaging 417
- Public Health, Environmental and Occupational Health 209
- Ophthalmology 176
- Cancer Research 54
- Genetics 53
Countries citing papers authored by Joel Sugar
This map shows the geographic impact of Joel Sugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Sugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Sugar more than expected).
Fields of papers citing papers by Joel Sugar
This network shows the impact of papers produced by Joel Sugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Sugar. The network helps show where Joel Sugar may publish in the future.
Co-authorship network of co-authors of Joel Sugar
This figure shows the co-authorship network connecting the top 25 collaborators of Joel Sugar. A scholar is included among the top collaborators of Joel Sugar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Sugar. Joel Sugar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Involvement of Sp1 elements in the promoter activity of genes affected in keratoconus. | 25 |
| 2 | Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas. | 60 |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 88 | |
| 7 | 33 | |
| 8 | 77 | |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 27 | |
| 12 | 53 | |
| 13 | 83 | |
| 14 | 1 | |
| 15 | 10 | |
| 16 | 1 | |
| 17 | [Keratoacanthoma of precarcinomatous character keratoacanthoma A and B)]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.